Jan 20 (Reuters) - Isomorphic Labs, which uses artificial intelligence for drug discovery, expects to have its first clinical trials by the end of 2026, founder and CEO Demis Hassabis said on Tuesday.

Add Yahoo as a preferred source to see more of our stories on Google. Demis Hassabis speaks during the 56th annual World Economic Forum (WEF) meeting in Davos, Switzerland, January 20, 2026.

ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO ...

Isomorphic Labs has raised $600m in its first external funding round as it pushes forward with artificial intelligence (AI)-driven drug discovery. Thrive Capital led the financing round, with ...

Dr. James McCaffrey presents a complete end-to-end demonstration of linear regression with pseudo-inverse training implemented using JavaScript. Compared to other training techniques, such as ...

A research team at the City University of New York and the University of Texas at Austin has discovered a way to make previously hidden states of light, known as dark excitons, shine brightly, and ...

While earlier stages of ovarian cancer are easier to treat than advanced stages, early stages cause very few noticeable symptoms. This isn’t the case for advanced, or late-stage, ovarian cancer.

Google DeepMind, the artificial intelligence company behind the popular AlphaFold tool, has published the next generation of the application’s protein structure prediction software. The new tool can ...

Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your inbox Get this delivered to your inbox, and ...

AdvancedMD provides the most comprehensive medical office software suite in the industry. Our EHR, billing and patient experience tools are used by more than 45,000 physicians and backed by expert ...

Subscribe to our weekly newsletter for the latest in industry news, expert insights, dedicated information security content and online events.